Close Menu

NEW YORK (GenomeWeb) – Israeli molecular diagnostics firm Pronto Diagnostics recently said that it has combined its suite of genetic tests with FDNA's Face2Gene phenotyping applications.

Pronto offers both next-generation sequencing-based gene panels and exome testing as well as single-gene molecular tests.

FDNA's Face2Gene technology uses facial analysis, deep learning, and artificial intelligence to improve molecular diagnostics. It enables clinicians to integrate phenotypic data into genetic testing pipelines in order to improve the chances of making a diagnosis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.